$1.33
0.00% yesterday
Nasdaq, May 20, 10:15 pm CET
ISIN
US68375N1037
Symbol
OPK
Sector
Industry

OPKO Health, Inc. Stock price

$1.33
-0.04 2.92% 1M
-0.25 15.82% 6M
-0.14 9.52% YTD
+0.01 0.76% 1Y
-1.76 56.96% 3Y
-1.39 51.10% 5Y
-16.69 92.62% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.00 0.00%
ISIN
US68375N1037
Symbol
OPK
Sector
Industry

Key metrics

Market capitalization $1.05b
Enterprise Value $1.11b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.61
P/S ratio (TTM) P/S ratio 1.53
P/B ratio (TTM) P/B ratio 0.68
Revenue growth (TTM) Revenue growth -13.79%
Revenue (TTM) Revenue $689.37m
EBIT (operating result TTM) EBIT $-269.22m
Free Cash Flow (TTM) Free Cash Flow $-206.24m
Cash position $436.00m
EPS (TTM) EPS $-0.08
P/E forward negative
P/S forward 1.62
EV/Sales forward 1.70
Short interest 7.50%
Show more

Is OPKO Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

OPKO Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a OPKO Health, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a OPKO Health, Inc. forecast:

Buy
86%
Hold
14%

Financial data from OPKO Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
689 689
14% 14%
100%
- Direct Costs 551 551
12% 12%
80%
138 138
21% 21%
20%
- Selling and Administrative Expenses 197 197
4% 4%
29%
- Research and Development Expense 114 114
45% 45%
17%
-173 -173
83% 83%
-25%
- Depreciation and Amortization 96 96
8% 8%
14%
EBIT (Operating Income) EBIT -269 -269
35% 35%
-39%
Net Profit -39 -39
85% 85%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about OPKO Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OPKO Health, Inc. Stock News

Neutral
GlobeNewsWire
6 days ago
MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in two investor conferences over the coming weeks. H.C. Wainwright 3 rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York City.
Neutral
Seeking Alpha
20 days ago
OPKO Health, Inc. (NASDAQ:OPK ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Yvonne Briggs - Alliance Advisors IR Dr. Phillip Frost - Chairman and CEO Dr. Elias Zerhouni - Vice Chairman and President Adam Logal - Chief Financial Officer Gary Nabel - Chief Innovation Officer Conference Call Participants Maury Raycroft - Jefferies Yi Chen - H. C. Wainwright & Co...
Neutral
GlobeNewsWire
about 2 months ago
MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company's existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO's common stock has been repurchased under the existing program since its author...
More OPKO Health, Inc. News

Company Profile

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Head office United States
CEO Phillip Frost
Employees 2,997
Founded 1991
Website www.opko.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today